InsideHealthPolicy.com, March 7, 2016. While minority, patient and consumer groups pushed for more diversity in the clinical trial phase, Jocelyn Ulrich director of scientific and regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said matching demographic subgroups based on sex, age and race, specifically the African American and Hispanic populations, to disease prevalence would extend phase III clinical trials by 20 months or longer.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Remedy for a Sick Industry
Portland Tribune, March 3, 2016. If he were playing it safe, Dr. Vinay Prasad might be among the last to turn into a medical provocateur. Prasad’s outspokenness and willingness to criticize industrywide assumptions place him in the ranks of a small but influential group of physicians and researchers who are either having an impact on the way medicine is practiced in the United States, or tilting at windmills.
Read More »Abortion Clinics vs. Cosmetic Surgery Centers: Which Are Safer for Women?
Our Bodies Ourselves Blog, March 4, 2016. The Supreme Court is trying to decide if regulating most abortion clinics out of existence places an undue burden on women’s access to safe and legal medical care. If legislators really want to protect women’s health, I want them to know that they can protect many more women, including many of their friends and loved ones, from far more dangerous medical procedures.
Read More »Olympus Settles Largest Kickback Lawsuit for a Medical Device Company in U.S. History
Plastics Today, March 2, 2016. Companies that put profit before consumer safety must be reprimanded, including Olympus Corp. for their infection spreading duodenoscopes.
Read More »Did the FDA’s Actions and the Essure Contraceptive Go Far Enough?
Forbes, March 1, 2016. Diana Zuckerman of The National Center for Health Research reports that “women and their doctors have been terribly misinformed about the complications [of Essure contraceptive], and that misinformation has greatly added to women’s suffering.”
Read More »